Low-dose post-transplant cyclophosphamide can mitigate GVHD and enhance the G-CSF/ATG induced GVHD protective activity and improve haploidentical transplant outcomes
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Low-dose post-transplant cyclophosphamide can mitigate GVHD and enhance the G-CSF/ATG induced GVHD protective activity and improve haploidentical transplant outcomes
Authors
Keywords
-
Journal
OncoImmunology
Volume 6, Issue 11, Pages e1356152
Publisher
Informa UK Limited
Online
2017-09-15
DOI
10.1080/2162402x.2017.1356152
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antithymocyte Globulin at Clinically Relevant Concentrations Kills Leukemic Blasts
- (2016) Rosy Dabas et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Haploidentical Hematopoietic Stem Cell Transplantation: A Global Overview Comparing Asia, the European Union, and the United States
- (2016) Jane Apperley et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Haploidentical versus Matched-Sibling Transplant in Adults with Philadelphia-Negative High-Risk Acute Lymphoblastic Leukemia: A Biologically Phase III Randomized Study
- (2016) Y. Wang et al. CLINICAL CANCER RESEARCH
- Impact of conditioning intensity in T-replete haplo-identical stem cell transplantation for acute leukemia: a report from the acute leukemia working party of the EBMT
- (2016) Marie T. Rubio et al. Journal of Hematology & Oncology
- Minimal residual disease- and graft-vs.-host disease-guided multiple consolidation chemotherapy and donor lymphocyte infusion prevent second acute leukemia relapse after allotransplant
- (2016) Chen-Hua Yan et al. Journal of Hematology & Oncology
- Haploidentical transplant for myelodysplastic syndrome: registry-based comparison with identical sibling transplant
- (2016) Y Wang et al. LEUKEMIA
- Haploidentical bone marrow and stem cell transplantation: experience with post-transplantation cyclophosphamide
- (2016) Tara M. Robinson et al. SEMINARS IN HEMATOLOGY
- Late-onset severe pneumonia after allogeneic hematopoietic stem cell transplantation: prognostic factors and treatments
- (2016) X.-D. Mo et al. Transplant Infectious Disease
- Lower incidence of acute GVHD is associated with the rapid recovery of CD4+CD25+CD45RA+ regulatory T cells in patients who received haploidentical allografts from NIMA-mismatched donors: A retrospective (development) and prospective (validation) cohort-based study
- (2016) Yu Wang et al. OncoImmunology
- Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study
- (2015) Yu Wang et al. BLOOD
- Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation sets
- (2015) Ying-Jun Chang et al. Journal of Hematology & Oncology
- Donor CD4+ Foxp3+ regulatory T cells are necessary for posttransplantation cyclophosphamide-mediated protection against GVHD in mice
- (2014) S. Ganguly et al. BLOOD
- Who is the best donor for a related HLA haplotype-mismatched transplant?
- (2014) Y. Wang et al. BLOOD
- HLA-haploidentical hematopoietic SCT from collateral related donors without in vitro T-cell depletion for hematological malignancies
- (2014) Y-y Zhang et al. BONE MARROW TRANSPLANTATION
- Antigen and Lymphopenia-Driven Donor T Cells Are Differentially Diminished by Post-Transplantation Administration of Cyclophosphamide after Hematopoietic Cell Transplantation
- (2013) Duncan Ross et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Influence of two different doses of antithymocyte globulin in patients with standard-risk disease following haploidentical transplantation: a randomized trial
- (2013) Y Wang et al. BONE MARROW TRANSPLANTATION
- Aldehyde Dehydrogenase Expression Drives Human Regulatory T Cell Resistance to Posttransplantation Cyclophosphamide
- (2013) C. G. Kanakry et al. Science Translational Medicine
- Haploidentical, unmanipulated, G-CSF-primed bone marrow transplantation for patients with high-risk hematologic malignancies
- (2012) P. Di Bartolomeo et al. BLOOD
- Long-term follow-up of haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of leukemia
- (2012) Yu Wang et al. CANCER
- Immune Reconstitution Following Unmanipulated HLA-Mismatched/Haploidentical Transplantation Compared with HLA-Identical Sibling Transplantation
- (2011) Ying-Jun Chang et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor
- (2009) Makoto Miyara et al. IMMUNITY
- HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
- (2008) Leo Luznik et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now